Lakewood-Amedex completes manufacturing steps for Nu-3 diabetes drug trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. IBM
10. KNX

Go back to Lakewood-Amedex completes manufacturing steps for Nu-3 diabetes drug trial
(NASDAQ: LABT) Delayed: 3.06 -0.35 (10.26%)
Previous Close $3.41    52 Week High $ 
Open $3.55    52 Week Low $ 
Day High $3.55    P/E N/A 
Day Low $2.77    EPS $ 
Volume 2,036,927